Vycor Medical (VYCO) Stock Price, News & Analysis

Company Overview

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

Key Stats

• Today's Range: $0.15 to $0.15
• 50-Day Range: $0.06 to $0.28
• 52-Week Range: $0.03 to $0.50
• Volume: 300 shs
• Average Volume: 20,329 shs
• Market Capitalization: $5.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VYCO Stock Analysis - Frequently Asked Questions

How have VYCO shares performed this year?

Vycor Medical's stock was trading at $0.0699 at the start of the year. Since then, VYCO shares have increased by 117.2% and is now trading at $0.1518.
View the best growth stocks for 2025 here.

How were Vycor Medical's earnings last quarter?

Vycor Medical, Inc. (OTCMKTS:VYCO) announced its quarterly earnings results on Monday, August, 17th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter. The medical device company earned $0.24 million during the quarter.

How do I buy shares of Vycor Medical?

Shares of VYCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vycor Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vycor Medical investors own include Fly Leasing (FLY), Idera Pharmaceuticals (IDRA), ACADIA Pharmaceuticals (ACAD), Bellicum Pharmaceuticals (BLCM), Canopy Growth (CGC), CorMedix (CRMD) and Drone Aviation (DRNE).

Company Calendar

• Last Earnings: 8/17/2020
• Today: 5/09/2025
• Next Earnings (Estimated): 5/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:VYCO
• Previous Symbol: OTCMKTS:VYCO
• CIK: 1424768
• Web: www.vycormedical.com
• Phone: (561) 558-2000
• Fax: 631-794-2444
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-70,000.00
• Net Margins: -13.46%
• Pretax Margin: -13.19%
• Return on Equity: N/A
• Return on Assets: -18.94%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.16
• Quick Ratio: 0.12

Sales & Book Value

• Annual Sales: $1.46 million
• Price / Sales: 3.24
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.10) per share
• Price / Book: -1.42

Miscellaneous

• Outstanding Shares: 33,424,000
• Free Float: 30,318,000
• Market Cap: $4.73 million
• Optionable: Not Optionable
• Beta: 0.11